XML 64 R52.htm IDEA: XBRL DOCUMENT
v3.22.4

Share Capital (Tables) | 9 Months Ended
--- | ---
Dec. 31, 2022
Equity [Abstract] |
Summary of Issuances of Stock Other | During the nine months ended December 31, 2022, the Company issued the following common shares, net of share issuance costs, as a result of business combinations, milestones being met, and other equity-settled transactions:
|  | Number of common shares |  |  | Share capital |  |  | Share based reserve |
Jetty Agreements |  |  | 8,426,539 |  |  | $ | 59,013 |  |  | $ | - |
HSCP Holders pursuant to Amended TRA |  |  | 5,648,927 |  |  |  | 20,630 |  |  |  | - |
Completion of acquisition milestones |  |  | 222,421 |  |  |  | 1,379 |  |  |  | (1,379 | )
Other issuances |  |  | 237,802 |  |  |  | 1,209 |  |  |  | (353 | )
Total |  |  | 14,535,689 |  |  | $ | 82,231 |  |  | $ | (1,732 | )
For the three and nine months ended December 31, 2022, the Company also issued 8,692,128 common shares with a value of $26,506 relating to its redemption of the redeemable noncontrolling interest in BioSteel. The redemption increases the Company's interest in BioSteel from 78.6% to 90.3%. During the nine months ended December 31, 2021, the Company issued the following common shares, net of share issuance costs, as a result of business combinations, milestones being met, and other equity-settled transactions:
|  | Number of common shares |  |  | Share capital |  |  | Share based reserve |
Acquisition of Supreme Cannabis |  |  | 9,013,400 |  |  | $ | 260,668 |  |  | $ | - |
Completion of acquisition milestones |  |  | 1,295,285 |  |  |  | 29,276 |  |  |  | (29,721 | )
Other issuances |  |  | 351,252 |  |  |  | 6,630 |  |  |  | (405 | )
Total |  |  | 10,659,937 |  |  | $ | 296,574 |  |  | $ | (30,126 | )
Summary of Warrants |
|  | Number of whole warrants |  |  | Average exercise price |  |  | Warrant value |
Balance outstanding at March 31, 2022 1 |  |  | 128,193,047 |  |  | $ | 58.04 |  |  | $ | 2,581,788 |
Expiry of warrants |  |  | - |  |  |  | - |  |  |  | - |
Balance outstanding at December 31, 2022 1 |  |  | 128,193,047 |  |  | $ | 58.04 |  |  | $ | 2,581,788 |
1 This balance excludes the Tranche C Warrants (as defined below), which represent a derivative liability and have nominal value. See Note 29.
|  | Number of whole warrants |  |  | Average exercise price |  |  | Warrant value |
Balance outstanding at March 31, 2021 1 |  |  | 127,073,136 |  |  | $ | 58.33 |  |  | $ | 2,568,438 |
Supreme Cannabis warrants |  |  | 1,265,742 |  |  |  | 25.61 |  |  |  | 13,350 |
Expiry of warrants |  |  | (145,831 | ) |  |  | 32.61 |  |  |  | - |
Balance outstanding at December 31, 2021 1 |  |  | 128,193,047 |  |  | $ | 58.04 |  |  | $ | 2,581,788 |
1 This balance excludes the Tranche C Warrants, which represent a derivative liability and have nominal value. See Note 29.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the equity interest issued or issuable in a business acquisition (or series of individually immaterial business acquisitions) planned, initiated, or completed during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(4) -URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479 + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration